Bhushan Shashi, Mahajan Supriya, Sen Aditya
Department of Paediatrics, School of Medical Sciences and Research, Sharda University, Greater Noida, UP, India.
Department of Microbiology, School of Medical Sciences and Research, Sharda University, Greater Noida, UP, India.
Med Mycol Case Rep. 2024 Jul 9;45:100659. doi: 10.1016/j.mmcr.2024.100659. eCollection 2024 Sep.
This study reports a case of multidrug resistant as the cause of early neonatal sepsis in a term small-for-gestational age neonate weighing 1680 g that successfully responded to voriconazole therapy. Both blood culture and urine culture of the neonate sent on day 4 and day 8 respectively showed Gram positive oval budding yeast cells on Gram staining which was confirmed as susceptible only to voriconazole by Vitek 2 Compact (Biomérieux, France) automated system. Voriconazole was given for fourteen days leading to good clinical response with microbiological clearance of fungus from blood and no side-effects.
本研究报告了一例孕周足月、出生体重1680g的小于胎龄新生儿,其早期新生儿败血症由多重耐药菌引起,对伏立康唑治疗反应良好。分别于第4天和第8天采集的新生儿血培养和尿培养,革兰氏染色均显示革兰氏阳性椭圆形芽生酵母细胞,经法国生物梅里埃公司的Vitek 2 Compact自动化系统确认,该菌仅对伏立康唑敏感。给予伏立康唑治疗14天,临床反应良好,血液中的真菌被清除,且无副作用。